Recruiting NCT06223880
This study is recruiting in the United States. It is testing Efficacy of AXS-05 Compared to Bupropion for depression.
Multiple locations, including Bellflower Depression Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Axsome Therapeutics, Inc.
Condition Depression Recruiting NCT07193901
This study is recruiting in China. It is testing Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray for depression.
Multiple locations, including Beijing Depression Drug From 18 Years to 64 Years
Countries China
Sponsor Sichuan Purity Pharmaceutical Technology Co., Ltd.
Condition Depression Recruiting NCT07196501
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
Multiple locations, including Oceanside Depression Drug Over 18 Years
Countries United States, Australia, Canada, ...
Sponsor Neurocrine Biosciences
Condition Depression Recruiting NCT07621237
This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
Multiple locations, including Phoenix Depression Drug Over 18 Years
Countries United States
Sponsor Tonix Pharmaceuticals, Inc.
Condition Depression Recruiting ISRCTN15349263
This study is recruiting in the United Kingdom. It focuses on Anxiety.
In United Kingdom Anxiety, Depression Other From 18 Years to 100 Years
Countries United Kingdom
Sponsor University of Liverpool
Condition Anxiety, Depression Recruiting ISRCTN11841241
This study is recruiting in the United Kingdom. It focuses on depression.
In United Kingdom Depression Other Over 65 Years
Countries United Kingdom
Sponsor Tees, Esk and Wear Valleys NHS Foundation Trust
Condition Depression Recruiting ISRCTN13501446
This study is recruiting. It focuses on anxiety and currently lists participation information in Colombia.
In Colombia Anxiety, Depression Other From 18 Years to 65 Years
Countries Colombia
Sponsor Queen Mary University of London
Condition Anxiety, Depression Recruiting ISRCTN41577200
This study is recruiting in Bolivia and in Guatemala. It focuses on Anxiety.
In Bolivia Anxiety, Depression Other From 18 Years to 75 Years
Countries Bolivia, Guatemala
Sponsor Queen Mary University of London
Condition Anxiety, Depression Recruiting NCT07047820
This study is recruiting in the United States. It focuses on depression.
In Woonsocket Depression Drug Over 18 Years
Countries United States
Sponsor Biogen
Condition Depression Recruiting ISRCTN91178137
This study is recruiting in the United Kingdom. It focuses on depression.
In United Kingdom Depression, Anxiety Other
Countries United Kingdom
Sponsor Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition Depression, Anxiety Recruiting ISRCTN57219158
This study is recruiting. It focuses on anxiety and currently lists participation information in Lebanon.
In Lebanon Anxiety, Depression Other From 18 Years to 34 Years
Countries Lebanon
Sponsor University of Bucharest
Condition Anxiety, Depression Recruiting NCT06958692
This study is recruiting. It focuses on depression and currently lists participation information in China.
In Beijing Depression Drug From 18 Years to 65 Years
Countries China
Sponsor CSPC Ouyi Pharmaceutical Co., Ltd.
Condition Depression 
